Password must be between 12-64 letters, numbers, and symbols long and contain no spaces.
Password must NOT contain a repeated character or sequence more than 3 characters long. For example: 1234, 1111, ABCD, AAAA.
Password must NOT contain 4 or more characters in the order they appear on a 'QWERTY' keyboard. For example: ASDFG.
Password must NOT contain your username.
Password must NOT be easy to guess. For example: 'VisualDx,' 'password,' and other passwords commonly found in data breaches.

Contents

Synopsis Codes Differential Diagnosis & Pitfalls Best Tests References

Hurthle cell carcinoma

Contents

Synopsis Codes Differential Diagnosis & Pitfalls Best Tests References

Other Resources UpToDate PubMed

Important News & Links

Hurthle cell carcinoma

Contributors: Carla Casulo MD

Other Resources UpToDate PubMed

Alerts and Notices

Important News & Links

Synopsis

Hurthle cell carcinoma : Cervical lymphadenopathy, Neck pain, Regional lymphadenopathy, Neck mass, Ionizing radiation exposure

A type of cancer consisting of large malignant cells of epithelial origin that are characterized by the presence of abundant granular eosinophilic cytoplasm known as oncocytes. Typical examples of oncocytic tumors include thyroid gland oncocytic follicular carcinoma, oncocytic breast carcinoma, renal oncocytic tumor, and salivary gland oncocytic carcinoma.

Codes

ICD10CM:
C73 – Malignant neoplasm of thyroid gland

SNOMEDCT:
423158009 – Hurthle cell carcinoma of thyroid

Differential Diagnosis & Pitfalls

To perform a comparison, select diagnoses from the classic differential

Subscription Required

Best Tests

Subscription Required

References

Subscription Required

Last Updated:01/17/2022

Hurthle cell carcinoma

A medical illustration showing key findings of Hurthle cell carcinoma : Cervical lymphadenopathy, Neck pain, Regional lymphadenopathy, Neck mass, Ionizing radiation exposure



Thank You!

We have sent an e-mail with this patient information.

OK

You have been logged out of VisualDx or your session has expired.

Please reload this page and sign into VisualDx to continue.



Send us your feedback

Thank You!

We appreciate your feedback and you will be hearing from us soon.

OK